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Summary DNA from 251 primary tumours obtained from 123 male and 125 female Norwegian patients with
colorectal carcinoma was analysed for the presence of K-ras point mutations at codons 12 and 13. Mutations
were found in 99 (39%) of the samples. The frequency of K-ras mutations was significantly related to age and
sex of the patients, and to the location of the tumours (overall: P = 0.008). K-ras mutations were much less
frequent in colonic tumours from male than female patients at younger ages (<40 years, odds ratio <0.014).
The low frequency might indicate that a different, ras-indendent pathway to neoplasia is dominating in the
colon of younger males. In contrast, older men had more mutations than older women (e.g. 90 years, odds
ratio = 5.8). An inverse but less pronounced relationship was seen for rectal tumours. The type of mutation
was found to be associated to sex of patient and location of tumour. G-+C transversions accounted for 35%
of the mutations in rectal tumours from females, in contrast to only 2.5% in the rest of the material
(P = 0.0005). This may indicate that there are specific carcinogens acting in this location.
Neoplastic transformation is believed to be the result of
accumulation of genetic alterations in a single cell during the
life of an individual. Tumour pathogenesis is increasingly
understood in terms of damage to critical regulatory genes
and the attendant deregulation of biochemical signalling
pathways in the cancer cell. The number of genes found to be
associated to different malignancies is growing rapidly. Single
base substitutions are the genetic change most frequently
found (Fearon & Vogelstein, 1990; Capella et al., 1991). The
ras oncogenes, together with the p53 tumour-suppressor
gene, are the genes most consistently found to be mutated in
colorectal cancer and a number of other malignancies
(Fearon & Vogelstein, 1990; Scott & Quirke, 1993). Single
base substitutions in codons 12, 13 or 61 result in an amino
acid alteration in the gene product (p21r'), activating the
oncogenic potential of the ras genes. The mutated protein is
believed to alter signal transduction pathways in a way that
stimulates clonal expansion of the cell (Barbacid, 1987; Bos,
1989).
In sporadic colon carcinomas, K-ras mutations have been
reported to occur in 40-60% of the cases (Burmer et al.,
1989, 1991; Capella et al., 1991), and ras mutation appears to
be a relatively early event in the adenoma-carcinoma
sequence (Fearon & Vogelstein, 1990; Hamilton, 1992). Little
is known about the cause and mechanism of activation of ras
and other oncogenes in the pathogenesis of human cancers.
In animal tumour model systems, specific carcinogens have
been found to induce distinct mutation patterns in ras genes
(Barbacid, 1988), but activation of ras in human tumours has
not been linked to any particular agents. Dietary factors,
colonic bacteria and bile composition are, however, related to
incidence of colorectal cancer (Reddy et al., 1992), and it is
thus believed that mutational events underlying these cancers
are caused by stool components.
Stool composition is known to vary with age and sex, and
to differ between different segments of the large bowel. We
therefore investigated if frequency or type of K-ras mutations
is related to any of these parameters.
Materials and methods
Patients and tumour samples
Fresh tissue samples from 251 primary colorectal adenocar-
cinomas removed during laparotomy of 123 male and 125
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female patients were analysed. The patients were between 24
and 94 years at the time of tumour extirpation (mean age 69
years). Four samples were obtained from different priipary
adenocarcinomas from a female patient with liver metastasis.
According to Turnbull's modification of Dukes' classification
(Dukes, 1932; Turnbull et al., 1967), the tumours were staged
from A to D (Table I). The location of the tumours is
illustrated in Figure 1. For comparisons between different
anatomical segments, we divided samples obtained from the
colon and the rectum into two separate groups. Rectum was
defined as the distal 15 cm of the large bowel. Subsegments
of the colon are also illustrated.
DNA extraction and in vitro amplification
Genomic DNA was extracted from fresh tumour cell suspen-
sions (Meling et al., 1992) using standard methods (Kunckel
et al., 1977). A 111 bp fragment of the K-ras gene (Genebank
accession no. L00045) was amplified using custom synthesised
oligonucleotide primers (Genosys Biotechnologies, TX, USA)
flanking the codons 12 and 13:
5KO: 5'-ATGACTGAATATAAACTTGT-3'
3K0: 5'-CTCTATTGTTGGATCATATT-3'
Each DNA sample (0.1 g) was added to 50jil of PCR buffer
(dNTP 0.25 mM each, potassium chloride 50 mM, magnesium
chloride 1.5 mM, Tris-HCl 10mM pH 8.4, gelatin 0.01%).
Each primer (20 pmol) and 2.5 units of Taq polymerase
(AmpliTaq DNA Polymerase, Perkin Elmer, CT, USA) were
added. Thirty-five cycles were performed on a DNA thermal
cycler (Perkin Elmer). One cycle consisted of 1 min denatura-
tion at 95°C, 1 min annealing at 56°C and 1 min elongation
at 72°C. After the last cycle the tubes were kept for 7 min at
the elongation temperature.
Identification ofK-ras mutations
Amplified DNA was slot blotted onto nylon membranes (Bio
Trace RP, Gelman Sciences, MI, USA). Samples containing
activated ras genes were identified using sequence-specific
oligonucleotide (SSO) hybridisation with a panel of 13 SSOs.
This included SSOs specific for all 12 point mutations in
codons 12 and 13 which result in amino acid substitutions, as
well as a wild-type probe (Muta-Lyzer oligonucleotide probe
panels, Clontech Laboratories, Palo Alto, CA, USA). The
probes were radiolabelled (32P) according to standard
methods (Sambrook, 1989). Hybridisation conditions were as
recommended by the manufacturer of the SSOs. Mismatched
SSOs were removed from the membrane-bound template by
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Table I Characteristics of the carcinomas and patients studied
No. with specific base substitution
No. of No. with (% of mutations')
tumours mutation (%) G+A G+T G+C
Sample size 251 99 (39.4) 57 (57) 34 (34) 9 (9)
Sex of patient
Male 123 41 (33.3) 27 (64.3) 14 (33.3) 1 (2.4)
Female 128 58 (45.3) 30 (51.7) 20 (34.5) 8 (13.8)
Location of tumour
Colon 143 59 (41.3) 37 (62.7) 21 (35.6) 1 (1.7)
Rectum 108 40 (37.0) 20 (48.8) 13 (31.7) 8 (19.5)
Dukes' stage of tumour
A 32 11 (34.4) 4 (36.4) 4 (36.4) 3 (27.3)
B 111 46 (41.4) 28 (60.9) 14 (30.4) 4 (8.7)
C 74 31 (41.9) 20 (62.5) 10 (31.3) 2 (6.3)
D 31b 10 (32.3) 5 (50.0) 5 (50.0) 0
ND 3 1 (33.3) 0 1 (100.0) 0
'In one tumour we found two different G-A transitions (total no. of mutations= 100).
bIncluding four primary carcinomas from one patient with liver metastasis.
Figure 1 Distribution of carcinomas and mutations. 0, no
mutation; *, G+A transition; *, G-*T transversion; A, G-*C
transversion, *, patient with four primary carcinomas; *, muta-
tions in both codons 12 and 13. Patients were divided by sex and
by younger and older than mean age. Percentage indicates fre-
quency of tumours with mutation in the group.
washing in TMAC (tetramethylammonium chloride) solution
as specified in the probe kit protocol. The remaining SSO-
template hybrids were identified by autoradiography at
-70'C for 1-4h.
DNA from blood of healthy individuals was tested with
the same procedure as the tumour samples and used as
references when reading the results. Sample reading was per-
formed visually. Cut-off was set at autoradiography signal
equal to the strongest signal of the negative controls, and
signals stronger than the negative controls were scored as
positive. After autoradiography, the membranes were dehy-
bridised, and hybridised sequentially to each of the 13 probes
of the panel.
Statistical analysis
Logistic regression analysis (Hosmer, 1989) was used to
determine which, if any, of the parameters age (AGE) and sex
(SEX) of patient, and location (LOC) and stage (STG) of
tumour correlated with K-ras mutations in the samples. All
four variables were considered candidates for the multivariate
models. Interaction terms among the variables were included
when relationships were indicated by univariate analysis.
Variables were kept in the model only if they or their interac-
tion terms improved the fit of the model (i.e. the change in
the scaled deviance corresponded to P<0.10).
AGE was scored as a continuous variable. SEX, LOC and
STG were scored as discontinuous variables with, respectively,
two (male, female), two (colon, rectum) and four (Dukes' A,
B, C, D) possible outcomes.
Statistical analyses were performed with the Statistica soft-
ware package (Release 4.0, Statsoft). All P-values are two-
tailed.
Results
Frequency ofK-ras mutations in colorectal carcinomas
The results are summarised in Table I and Figure 1. We
found point mutations in 99 of the 251 tumour samples
(39%). In addition, one of the samples was found to contain
both a codon 12 and a codon 13 point mutation. Among the
four different samples obtained from one patient, two were
found to contain the same mutation, one had a different base
substitution, and in one only the wild-type gene could be
detected.
To investigate if differences in frequency of tumours with
K-ras mutations were associated with other variables, we
constructed a logistic model with presence of mutation as the
dependent variable. The final model included SEX (p= - 9.024,
s.e. = 3.052, P = 0.003), AGE (p = -0.024, s.e. = 0.024,
P = 0.324), LOC (13= -3.991, s.e. = 2.520, P = 0.115), SEX-
AGE interaction (13 = 0.120, s.e. = 0.042, P = 0.004) AGE-LOC
interaction (13 = 0.056, s.e. = 0.036, P= 0.121), SEX-LOC
interaction (p = 10.354, s.e. = 3.861, P = 0.008) and SEX-LOC-
AGE interaction (p = -0.147, s.e. = 0.054, P = 0.007); overall
significance of model, x2 = 19.2, P = 0.008 (7 d.f.). The SEX-
LOC-AGE interaction was included to take account for the
low frequency of mutations in colonic tumours of younger
men. The model was used to estimate the odds ratio for
mutation in males compared with females at different ages
and locations (Table II). This table illustrates how this ratioK-ras MUTATION IN COLORECTAL CANCER 369
Table II Estimated odds ratio for mutation in males compared with females, controlled for age and
location
LOC (location of AGE (age of patients) (years)
tumours) 20 30 40 50 60 70 80 90
Colon 0.0013 0.0044 0.014 0.048 0.16 0.53 1.7 5.8
Rectum 2.2 1.7 1.3 0.96 0.73 0.55 0.42 0.32
The values indicate an approximation of how much more likely it is for K-ras mutations to be
present among male than among female colorectal cancer patients at different ages and locations.
of mutations varies for the colon and rectum. For colonic
tumours, young men have significantly fewer mutations than
young women, but this difference disappears at higher ages.
Rectal tumours show an inverse but less pronounced rela-
tionship. Stage of tumour (STG) did not contribute to this
model.
Mutation spectrum ofK-ras in colorectal carcinomas
The distribution of the specific nucleotide changes at codon
12 and 13 of the 100 mutations identified is shown in Figure
2. The most frequent mutations were G-*A transitions (57/
100) and G-*T transversions (34/100). Only nine G-*C
transversions were observed. Mutations in position 2 of a
codon occurred approximately three times more frequently
than mutations in position 1 (76% vs 24%).
Separate logistic models were constructed for comparing
distribution of each types of base substitution with the other
mutations. Associations to other variables were only
significant for the G-*C transversions: SEX (p = - 2.054,
s.e. = 1.129, P = 0.067), LOC (p = 2.805, s.e. = 1.097,
P = 0.012); overall significance of model, X2 = 15.2,
P = 0.0005 (2 d.f.). In Figure 1 it is illustrated how eight of
the nine tumours containing G-*C transversions were localised
to the rectum; seven of these were from female patients. This
base substitution accounted for 35% of the mutations found
in rectal tumours from females, in contrast to only 2.5% in
the other tumours. G-*C transversions contributed to 27%
of stage A tumours, and none was detected in Dukes' D
tumours. STG was not included in the model because the
change in the scaled deviance (P = 0.11) just exceeded the
limit for inclusion.
G-*A transition in position 2 of codon 13, resulting in a
Gly-*Asp substitution in p2l'rz, has been found to occur
predominantly in colorectal carcinomas of older patients
(Capella et al., 1991). When analysing for the distribution of
this mutation in our material we found no such associa-
tion.
Discussion
In this study of 251 colorectal carcinomas, we found one or
more ras mutations in 39% of the samples. Our results show
that the frequency of carcinomas containing activated K-ras
is dependent on age and sex of the patients as well as
location of the tumours. We also found the pattern of base
substitutions to be associated to age and sex of patient, and
location of tumours. At the two extremes, no ras mutations
were found in tumours located proximal to the descending
colon of men younger than 70 years of age, whereas rare
mutations such as G->C transversions were almost exclus-
ively observed in tumours of the rectum of women.
The frequency of mutation-bearing tumours in this
material is similar to other reports based on the same techni-
que to identify K-ras mutations in codons 12 and 13
(Laurent-Puig et al., 1991; Bos et al., 1987). The method
detects DNA samples containing 10% or more of the
mutated species (20% of heterozygous cells). More sensitive
techniques based on sequencing the gene from carefully
selected tumour tissue (Burmer et al., 1989, 1991) indicate
that the actual frequency of K-ras mutations in colorectal
cancers is somewhat higher (50-60%). By only testing for
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Figure 2 Frequencies of the different base substitutions among
tumours having mutation. Columns represent the percentage of
tumours with the indicated mutation in codon 12 or 13.
mutations in codons 12 and 13 of K-ras, we failed to detect
possible mutations in codon 61 of K-ras and codons 12, 13
and 61 of N-ras. These could account for as many as 14% of
all ras mutations in colorectal cancer (Vogelstein et al., 1988).
Thus we have probably underestimated the number of muta-
tions in this material.
In populations of both low and high incidence of colon
cancer, the incidence of cancer of the caecum and ascending
colon is, typically, 10-20% higher in women than in men
(McMicheal & Potter, 1983, 1985). This incidence is in direct
contrast to the incidence of cancer in the descending and
sigmoid colon, for which the sex ratio (male-female) of
cancer incidence with increasing age becomes progressively
and substantially greater than unity. For rectal cancer, male
and female rates are similar at younger ages, but male rates
increasingly predominate at older ages (McMicheal & Potter,
1983). In our material, we found frequency of ras mutations
to differ significantly with respect to age and sex of patients,
and location of tumour. This might indicate that there is an
association between activation of K-ras and the differences in
incidence of colorectal cancer described above.
The most striking observation was the generally low fre-
quency of tumours with ras mutation in the colon of younger
male patients, and even a complete absence of such tumours
in the proximal colon among these patients (Figure 1). It is
therefore of interest that the incidence of cancer in the proxi-
mal colon is reported to be higher in women than in men at
all ages. Our results indicate that this sex difference may be
related to a low frequency of K-ras mutation-bearing
tumours in male patients. The logistic model based on these
data suggests that only at high ages (>80) does the fre-
quency of mutation among men exceed that of women. The
ras activation in (proximal) colonic tumours might therefore
be promoted by intrinsic or environmental factors related to
females.
Several lines of evidence strongly suggest that female sex
hormones, via their effects on bile acid production, bowel
transit time and, possibly, bacterial fermentation and produc-
tion of volatile fatty acids, are related to colorectal car-370 J. BREIVIK et al.
cinogenesis. Alterations in the amount and composition of
enterohepatically circulating bile acids are highly related to
the risk of proximal colon cancer (McMicheal & Potter,
1983, 1985). The carcinogenic effects of the bile components,
deoxycholic acid and lithocholic acid are therefore of special
interest for possible induction of ras mutations in this loca-
tion.
Our results are compatible with the observation that
different combinations of genetic alterations may result in a
malignant phenotype (Fearon & Vogelstein, 1990; Scott &
Quirke, 1993; McLellan et al., 1993). Thus, some pathways
to colorectal cancer may require a mutation in the K-ras
gene, while others may not. This is illustrated by the findings
in one patient in whom material from four carcinomas,
distributed through the large bowel, was available. While the
two distal tumours contained different base substitutions,
only one of the two proximal tumours had a detectable
mutation. These carcinomas have probably developed by
independent mutational events and by different pathways.
Our results suggest that the ras-independent pathway(s)
dominates in colon cancer of younger men (Table II, Figure
1). In this context it is of interest that patients of both sexes
with hereditary non-polyposis colorectal carcinomas
(HNPCCs), develop tumours at an early age and preferen-
tially in the proximal colon (Lynch et al., 1992). A gene that
is most likely responsible for these tumours has recently been
localised to chromosome 2 (2pl5-16) (Peltomaki et al.,
1993). If this gene participates in a distinct ras-independent
pathway, one would not expect to find ras mutations in
colorectal cancers from HNPCC patients. However, the
hypothesis is not supported by a recent report describing a
61% frequency of K-ras mutations in 18 tumours from
HNPCC patients (Aaltonen et al., 1993). This high frequency
is compatible with the notion that the HNPCC gene may be
an altered replication factor that would accelerate the
accumulation of somatic mutations, thus promoting cancer at
early ages.
Studies in the field of animal carcinogen-induced tumour
model systems reveal distinct ras mutation patterns specific
for each carcinogen (Barbacid, 1988). The concentration of
tumours containing G-*C transversions in the rectum of
female patients might therefore be the result of one or more
distinct carcinogens acting in this location. Bile composition
shows little relation to cancer in the rectum, consistent with
the fact that most bile acid is reabsorbed in the proximal
colon. The relatively high frequency of this mutation in
females might therefore be related to sex differences in faecal
concentration and transit time. Both bowel transit time and
prevalence of constipation have been reported to be substan-
tially higher in females than in males (McMicheal & Potter,
1983; Lampe et al., 1993). The G-*C transversions and also
the generally higher frequency of K-ras mutations in women
might thus be related to the time of contact with, and the
concentration of, particular carcinogens.
The differences in the prevalence and pattern of K-ras
mutations in relation to patient age and sex, and tumour
location described here may constitute a starting point for
identifying the agents causing such mutations.
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